We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,704
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKR icon
6651
Ark Restaurants
ARKR
$20.2M
$20K ﹤0.01%
806
+136
+20% +$3.43K
ATOS icon
6652
Atossa Therapeutics
ATOS
$23.8M
$20K ﹤0.01%
609
+393
+182% +$21.1K
AVTX icon
6653
Avalo Therapeutics
AVTX
$997M
$20K ﹤0.01%
+2
New +$23.8K
BANX
6654
ArrowMark Financial
BANX
$198M
$20K ﹤0.01%
876
-634
-42% -$13.9K
BGI icon
6655
Birks Group
BGI
$10.4M
$20K ﹤0.01%
15,617
+4,587
+42% +$5.83K
CLS icon
6656
Celestica
CLS
$41.7B
$20K ﹤0.01%
+1,720
New +$19.7K
FNKO icon
6657
Funko
FNKO
$314M
$20K ﹤0.01%
1,540
-474
-24% -$4.64K
FORM icon
6658
FormFactor
FORM
$8.92B
$20K ﹤0.01%
1,498
-2,282
-60% -$30.9K
HFFG icon
6659
HF Foods Group
HFFG
$78.1M
$20K ﹤0.01%
+2,000
New +$20.1K
HSDT icon
6660
Solana Company
HSDT
$100M
0
AGIG
6661
Abundia Global Impact Group
AGIG
$40.7M
$20K ﹤0.01%
517
+492
+1,968% +$15.7K
IMNN icon
6662
Imunon
IMNN
$6.68M
$20K ﹤0.01%
34
+8
+31% +$3.97K
NL icon
6663
NLI Holdings
NL
$281M
$20K ﹤0.01%
2,289
+1,924
+527% +$16.5K
PRPL icon
6664
Purple Innovation
PRPL
$40.3M
$20K ﹤0.01%
95
+30
+46% +$6.27K
QTRX icon
6665
Quanterix
QTRX
$177M
$20K ﹤0.01%
1,414
+1,155
+446% +$20K
TAIL icon
6666
Cambria Tail Risk ETF
TAIL
$146M
$20K ﹤0.01%
952
-215
-18% -$4.6K
VANI icon
6667
Vivani Medical
VANI
$119M
$20K ﹤0.01%
496
-111
-18% -$4.83K
USAP
6668
DELISTED
Universal Stainless & Alloy
USAP
$20K ﹤0.01%
824
+586
+246% +$15.9K
REED
6669
DELISTED
Reeds, Inc. Common Stock
REED
$20K ﹤0.01%
+137
New +$17.3K
ZEAL
6670
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$20K ﹤0.01%
+1,610
New +$24.5K
SFHY
6671
DELISTED
WisdomTree U.S. Short Term High Yield Corporate Bond Fund
SFHY
$20K ﹤0.01%
+410
New +$20.3K
TALO.WS
6672
DELISTED
Talos Energy, Inc. Warrants to purchase common stock (expiring February 28, 2021)
TALO.WS
$20K ﹤0.01%
+4,278
New +$21.6K
PER
6673
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$20K ﹤0.01%
7,761
+3,770
+94% +$8.64K
JPLS
6674
DELISTED
JPMorgan Long/Short ETF
JPLS
$20K ﹤0.01%
900
+400
+80% +$9.32K
EXIV
6675
DELISTED
VelocityShares 1x Daily Inverse VSTOXX Futures ETN
EXIV
$20K ﹤0.01%
+629
New +$22.7K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,704 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.